Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-005890

CVP, JAPAC sold 857 shares at $85.60 ($73,359)

  • CVP, JAPAC gave up 586 shares (to pay taxes)
  • CVP, JAPAC acquired 857 shares (option exercise)
  • CVP, JAPAC acquired 7,560 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lippis Daniel J. · CVP, JAPAC

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-07 Grant or award : show line 1 in the form 10b5-1 +4,660 21,575.74 D
2024-05-07 Grant or award : show line 2 in the form 10b5-1 +2,900 24,475.74 D
2024-05-07 Exercise or conversion : show line 3 in the form 10b5-1 +857 $36.75 $31,495 25,332.74 D
2024-05-07 Shares withheld for taxes : show line 4 in the form 10b5-1 −586 $85.09 $49,863 24,746.74 D
2024-05-07 Sale : show line 5 in the form 10b5-1 −857 $85.60 $73,359 23,889.74 D
Open-market sales · 857 sh · avg $85.60 · $73,359

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-05-07 Grant or award : show line 6 in the form 10b5-1 Employee Stock Option (Right to Acquire) +15,500 15,500 D
2024-05-07 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Acquire) −857 0 D
2024-05-07 Grant or award : show line 8 in the form 10b5-1 Performance Rights +2,900 2,900 D
Loading xslF345X05/doc4.xml…